Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Income towards Parent Company (2020 - 2025)

Historic Income towards Parent Company for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to -$11.0 million.

  • Insight Molecular Diagnostics' Income towards Parent Company rose 1825.38% to -$11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.3 million, marking a year-over-year decrease of 12479.84%. This contributed to the annual value of -$61.0 million for FY2024, which is 198615.86% down from last year.
  • Per Insight Molecular Diagnostics' latest filing, its Income towards Parent Company stood at -$11.0 million for Q3 2025, which was up 1825.38% from -$9.8 million recorded in Q2 2025.
  • Insight Molecular Diagnostics' Income towards Parent Company's 5-year high stood at -$2.9 million during Q1 2023, with a 5-year trough of -$35.7 million in Q4 2021.
  • For the 5-year period, Insight Molecular Diagnostics' Income towards Parent Company averaged around -$13.5 million, with its median value being -$10.1 million (2022).
  • Per our database at Business Quant, Insight Molecular Diagnostics' Income towards Parent Company crashed by 43856.95% in 2021 and then skyrocketed by 7156.74% in 2023.
  • Insight Molecular Diagnostics' Income towards Parent Company (Quarter) stood at -$35.7 million in 2021, then rose by 7.65% to -$33.0 million in 2022, then soared by 91.12% to -$2.9 million in 2023, then crashed by 1049.25% to -$33.6 million in 2024, then skyrocketed by 67.15% to -$11.0 million in 2025.
  • Its last three reported values are -$11.0 million in Q3 2025, -$9.8 million for Q2 2025, and -$6.8 million during Q1 2025.